Clinical trial transparency has risen, reports ABPI

Some 90 per cent of industry-led pharmaceutical trials are now published, according to the Association of British Pharmaceutical Industry.

The disclosure rate increased from 71 per cent in 2009 to 90 per cent in 2013, the association said. This represents a “significant trend” towards increased clinical trial transparency, it added. 

The claim is based on a report, Clinical trial transparency of recently approved medicines, published on 24 November. The study covers the clinical trials of 34 medicines that were approved by the European Medicines Agency in 2013.